ÂÜÀòÂÒÂ×

Lars Ohman is an accomplished executive with extensive experience in the pharmaceutical and biotechnology sectors. Currently serving as Chairman of the Board and Senior Advisor for Lipigon Pharmaceuticals AB, Lars Ohman has been integral to the company's focus on developing novel therapies for lipid disorders. In addition to leading Immunscape as CEO and holding directorial roles at Cordator Life Science AB and Kubator Therapeutics AB, Lars Ohman has significantly contributed to the creation and commercialization of immunotherapy drugs and orphan medicines. Notable prior experiences include leadership positions at Karo Bio AB, where Lars Ohman was involved in drug discovery collaborations with major pharmaceutical companies. Lars Ohman holds an MBA from the Stockholm School of Economics and has a background in biochemical engineering from KTH Royal Institute of Technology.